{"schema_version":"secwatch.filing_event.v1","accession":"0001171520-22-000364","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2022-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.085489+00:00","generated_at":"2026-06-25T04:13:51.936661+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"ClearPoint Neuro nullifies authorized share decrease after proxy statement error","bullets":["At May 24, 2022 Annual Meeting, stockholders approved decreasing authorized shares from 200M to 80M.","Beneficial owner questioned proxy statement inaccuracy on broker discretionary voting for the share decrease proposal.","Company filed Certificate of Correction on June 3, 2022 to nullify the previously filed Certificate of Amendment.","Company will seek stockholder approval again at a future meeting to achieve modest Delaware franchise tax savings."],"urls":{"canonical":"https://secwatch.observer/filing/0001171520-22-000364","json":"https://secwatch.observer/filing/0001171520-22-000364.json","markdown":"https://secwatch.observer/filing/0001171520-22-000364.md","text":"https://secwatch.observer/filing/0001171520-22-000364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000364/0001171520-22-000364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000364/eps10300.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:13:51.936661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}